Salisbury Internal Medicine is categorized under Internal Medicine Doctors in Salisbury, NC and active since 1981.
Salisbury Internal Medicine was established in 1981, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas Ginn, Owner at the company’s single location by writing to 319 Mocksville Avenue, Salisbury, North Carolina NC 28144 or by phoning (704) 637-3538. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Salisbury Internal Medicine |
Contact Person: | Thomas Ginn, Owner |
Address: | 319 Mocksville Avenue, Salisbury, North Carolina 28144 |
Phone Number: | (704) 637-3538 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1981 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Salisbury Internal Medicine was started in 1981 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas Ginn, Owner for inquiries that concern Salisbury Internal Medicine by calling the company number (704) 637-3538, as your correspondence is most welcome. Additionally, the physical location of the single location of Salisbury Internal Medicine can be found at the coordinates 35.67898,-80.47146 as well as the street address 319 Mocksville Avenue in Salisbury, North Carolina 28144.
For its online presence, you may visit Salisbury Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.